• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部全层切除术治疗无蒂性腺瘤和 cT1-2 期直肠肿瘤:长期肿瘤学结果。

Local full-thickness excision for sessile adenoma and cT1-2 rectal cancer: long-term oncological outcome.

机构信息

Department of Surgery, "Lozano Blesa" University Hospital, San Juan Bosco 15, 50009, Saragossa, Spain.

Department of Microbiology, Preventive Medicine and Public Health, University of Zaragoza, Domingo Miral s/n 50009-Saragossa, Spain.

出版信息

Langenbecks Arch Surg. 2022 Sep;407(6):2431-2439. doi: 10.1007/s00423-022-02593-7. Epub 2022 Jun 22.

DOI:10.1007/s00423-022-02593-7
PMID:35732844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9467953/
Abstract

PURPOSE

We analyzed all patients who underwent local transanal surgery at our institution to determine oncological outcomes and perioperative risk.

METHODS

In 1997, we developed a prospective protocol for rectal tumors: transanal local full-thickness excision was considered curative in patients with benign adenoma and early cancers. In this analysis, 404 patients were included. To analyze survival, only those patients exposed to the risk of dying for at least 5 years were considered for the study.

RESULTS

The final pathological analysis revealed that 262 (64.8%) patients had benign lesions, whereas 142 had malignant lesions. Postoperative complications were recorded in 12.6%. At the median time of 21 months, 14% of the adenomas and 12% of cancers had recurred, half of which were surgically resected. The overall 5-year survival rate was 94%.

CONCLUSION

With similar outcomes and significantly lower morbidity, we found local surgery to be an adequate alternative to radical surgery in selected cases of early rectal cancer.

摘要

目的

我们分析了在我院接受局部经肛门手术的所有患者,以确定肿瘤学结果和围手术期风险。

方法

1997 年,我们制定了直肠肿瘤的前瞻性方案:对于良性腺瘤和早期癌症患者,经肛门局部全层切除术被认为是治愈性的。在本分析中,纳入了 404 例患者。为了分析生存情况,仅考虑了至少有 5 年死亡风险的患者。

结果

最终的病理分析显示 262 例(64.8%)患者为良性病变,而 142 例为恶性病变。术后并发症发生率为 12.6%。在 21 个月的中位时间内,14%的腺瘤和 12%的癌症复发,其中一半经手术切除。总的 5 年生存率为 94%。

结论

我们发现,对于早期直肠癌的某些特定病例,局部手术与根治性手术相比具有相似的结果和显著更低的发病率,是一种充分的替代选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0261/9467953/4e4c33570279/423_2022_2593_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0261/9467953/a1f319cbf19e/423_2022_2593_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0261/9467953/4e4c33570279/423_2022_2593_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0261/9467953/a1f319cbf19e/423_2022_2593_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0261/9467953/4e4c33570279/423_2022_2593_Fig2_HTML.jpg

相似文献

1
Local full-thickness excision for sessile adenoma and cT1-2 rectal cancer: long-term oncological outcome.局部全层切除术治疗无蒂性腺瘤和 cT1-2 期直肠肿瘤:长期肿瘤学结果。
Langenbecks Arch Surg. 2022 Sep;407(6):2431-2439. doi: 10.1007/s00423-022-02593-7. Epub 2022 Jun 22.
2
Management and outcome of local recurrence following transanal endoscopic microsurgery for rectal cancer.经肛门内镜微创手术治疗直肠癌后局部复发的处理与结局。
Dis Colon Rectum. 2012 Mar;55(3):262-9. doi: 10.1097/DCR.0b013e318241ef22.
3
Transanal endoscopic microsurgery for rectal neoplasms. How I do it.经肛门内镜微创手术治疗直肠肿瘤。我的经验分享。
J Gastrointest Surg. 2013 Mar;17(3):586-92. doi: 10.1007/s11605-012-2060-x. Epub 2012 Oct 24.
4
Transanal endoscopic microsurgery for rectal tumors: experience at Korea's National Cancer Center.经肛门内镜微创手术治疗直肠肿瘤:韩国国家癌症中心的经验。
Surg Endosc. 2009 Nov;23(11):2575-9. doi: 10.1007/s00464-009-0466-7. Epub 2009 Apr 4.
5
[Transanal endoscopic microsurgery in the treatment of rectal tumors: a prospective study in 50 patients].经肛门内镜显微手术治疗直肠肿瘤:50例患者的前瞻性研究
Arq Gastroenterol. 2008 Oct-Dec;45(4):268-74. doi: 10.1590/s0004-28032008000400003.
6
Completion Surgery in Unfavorable Rectal Cancer after Transanal Endoscopic Microsurgery: Does It Achieve Satisfactory Sphincter Preservation, Quality of Total Mesorectal Excision Specimen, and Long-term Oncological Outcomes?经肛门内镜微创手术(TEM)后行补救性手术治疗不利直肠癌:是否能够达到满意的肛门括约肌保留效果、全直肠系膜切除标本质量以及长期肿瘤学结局?
Dis Colon Rectum. 2021 Feb 1;64(2):200-208. doi: 10.1097/DCR.0000000000001730.
7
Recurrence after transanal endoscopic microsurgery for large rectal adenomas.经肛门内镜微创手术切除大型直肠腺瘤后的复发。
Surg Endosc. 2012 Sep;26(9):2594-600. doi: 10.1007/s00464-012-2238-z. Epub 2012 Apr 5.
8
Postoperative morbidity and recurrence after local excision of rectal adenomas and rectal cancer by transanal endoscopic microsurgery.经肛门内镜显微手术对直肠腺瘤和直肠癌进行局部切除后的术后发病率及复发情况。
Colorectal Dis. 2005 Mar;7(2):133-7. doi: 10.1111/j.1463-1318.2004.00724.x.
9
Transanal endoscopic microsurgery in rectal adenomas: experience of six Italian centres.经肛门内镜显微手术治疗直肠腺瘤:六个意大利中心的经验
Dig Liver Dis. 2006 Mar;38(3):202-7. doi: 10.1016/j.dld.2005.11.014. Epub 2006 Feb 7.
10
Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.新辅助放化疗后残留直肠癌(ypT0-2)经肛门内镜微创手术:另需谨慎。
Dis Colon Rectum. 2013 Jan;56(1):6-13. doi: 10.1097/DCR.0b013e318273f56f.

引用本文的文献

1
Local excision for middle-low rectal cancer after neoadjuvant chemoradiation: A retrospective study from a single tertiary center.新辅助放化疗后中低位直肠癌的局部切除:来自单一三级中心的回顾性研究
World J Gastrointest Oncol. 2024 Dec 15;16(12):4614-4624. doi: 10.4251/wjgo.v16.i12.4614.

本文引用的文献

1
Completion surgery vs. primary TME for early rectal cancer: a national study.保肛手术与经肛局部切除治疗早期直肠癌的对比:全国性研究
Int J Colorectal Dis. 2022 Feb;37(2):429-435. doi: 10.1007/s00384-021-04083-6. Epub 2021 Dec 16.
2
Robotic transanal minimally invasive surgery - technical, oncological and patient outcomes from a single institution.机器人经肛门微创手术——来自单一机构的技术、肿瘤学及患者预后情况
Colorectal Dis. 2020 Oct;22(10):1422-1428. doi: 10.1111/codi.15045. Epub 2020 May 19.
3
Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.
局部切除与全直肠系膜切除术治疗 T1/T2 期中低位直肠癌及中危病理患者的生存分析。
World J Surg Oncol. 2019 Dec 9;17(1):212. doi: 10.1186/s12957-019-1763-9.
4
Transanal endoscopic microsurgery for rectal villous tumours: Can we rely solely on preoperative biopsies and the surgeon’s experience?经肛门内镜微创手术治疗直肠绒毛状肿瘤:我们能否仅依靠术前活检和外科医生的经验?
Can J Surg. 2019 Dec 1;62(6):454-459. doi: 10.1503/cjs.012416.
5
Local excision followed by early radical surgery in rectal cancer: long-term outcome.局部切除加早期根治性手术治疗直肠癌:长期疗效。
World J Surg Oncol. 2019 Oct 8;17(1):168. doi: 10.1186/s12957-019-1705-6.
6
Predictors of rectal adenoma recurrence following transanal endoscopic surgery: a retrospective cohort study.经肛门内镜微创手术后直肠腺瘤复发的预测因素:一项回顾性队列研究。
Surg Endosc. 2020 Aug;34(8):3398-3407. doi: 10.1007/s00464-019-07114-0. Epub 2019 Sep 11.
7
Overall survival of colorectal cancer by stage at diagnosis: Data from the Martinique Cancer Registry.根据诊断分期的结直肠癌总生存率:来自马提尼克癌症登记处的数据。
Medicine (Baltimore). 2019 Aug;98(35):e16941. doi: 10.1097/MD.0000000000016941.
8
Locally Excised T1 Rectal Cancers: Need for Specialized Surveillance Protocols.局部切除的 T1 直肠肿瘤:需要专门的监测方案。
Dis Colon Rectum. 2019 Sep;62(9):1055-1062. doi: 10.1097/DCR.0000000000001439.
9
Transanal endoscopic microsurgery for rectal lesions in a specialist regional early rectal cancer centre: the Mersey experience.直肠病变的经肛门内镜微创手术:默西塞德经验-一家专业的区域性早期直肠癌中心
Colorectal Dis. 2019 Oct;21(10):1164-1174. doi: 10.1111/codi.14730. Epub 2019 Jul 1.
10
Accuracy of endoscopic ultrasound in rectal cancer and its use in transanal endoscopic microsurgery.内镜超声在直肠癌中的准确性及其在经肛门内镜显微手术中的应用。
Minim Invasive Ther Allied Technol. 2020 Apr;29(2):90-97. doi: 10.1080/13645706.2019.1585373. Epub 2019 Mar 8.